Head-to-head · Value Score
CoreAge Rx vs Luvo Health
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 81, Luvo Health a 66. Here's what each one really costs past month one — and where each one bites back.
CoreAge Rx
Grade B · Good Value
Advertised price
From $79/mo
From $79/mo (compounded semaglutide; confirm total at checkout)
Luvo Health
Grade C · Watch List
Advertised price
$209 every 4 weeks
$209 every 4 weeks (semaglutide injection; first 4 weeks half price)
The verdict
CoreAge Rx takes it on Value Score, 81 to 66 — an est. From $79/mo (compounded semaglutide; confirm total at checkout) first month, though we flag its pricing to watch. Luvo Health isn't out of it: Shoppers who want a genuine oral tablet or brand-name option alongside compounded injectables, and who will read the term-length ladder rather than anchor on the 4-week price alone.
CoreAge Rx is a featured partner of this site. Its advertised prices have checkout conditions, and state eligibility is confirmed during intake.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Luvo Health |
|---|---|---|
| Value Score | 81 (B) | 66 (C) |
| Advertised price | From $79/mo (compounded semaglutide; confirm total at checkout) | $209 every 4 weeks (semaglutide injection; first 4 weeks half price) |
| Save vs brand self-pay | — | — |
| Semaglutide | From $79/mo (compounded injection; confirm total at checkout) | $209 every 4 weeks (injection) or $259 every 4 weeks (tablets), first 4 weeks half price ($104.50 / $129.50); microdose $179 every 4 weeks; longer plans up to 24 weeks cost less; brand Ozempic® also available |
| Tirzepatide | From $129/mo (compounded injection; confirm total at checkout) | $249 every 4 weeks (injection), first 4 weeks half price ($124.50); microdose $179 every 4 weeks; longer plans up to 24 weeks cost less; brand Zepbound® also available |
| Both molecules | Yes | Yes |
| Pricing | Watch | Watch |
| Coverage | U.S., state limits shown at intake | Not disclosed |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
CoreAge Rx advertises compounded semaglutide from $79 and tirzepatide from $129 per month, with dose-flat pricing stated in its FAQ. Confirm the total and refund terms before paying.
What's good
- CoreAge Rx publishes separate product prices for both molecules: semaglutide from $79 per month and tirzepatide from $129. That gives you two actual medication offers to compare rather than one generic GLP-1 starting figure.
- CoreAge Rx's FAQ says the price locked in at checkout stays the same in future months regardless of dose increases. I would save that confirmation with the order, because a low starting price matters much more when the prescribed maintenance dose costs the same.
- The product pages state that there are no long-term contracts or membership fees and advertise fast, free delivery. Compare those inclusions with the checkout total; the refund policy separately allows applicable consultation fees and shipping charges if disclosed there.
- CoreAge Rx uses the MD Integrations professional entities for medical care and prescribing. Its FAQ names physicians assigned in California, Massachusetts, Rhode Island and Vermont, giving patients in those states a concrete medical contact to verify.
- CoreAge Rx offers account-based reordering and cancellation, and its help center says optional subscriptions can be managed in the member portal. Check whether your selected purchase is a one-time order or an automatically renewed subscription so the next charge is predictable.
- CoreAge Rx also advertises microdosing products at $79 for semaglutide and $129 for tirzepatide. These are separate lower-dose offers, not a reason to select your own dose or evidence that they work like the doses studied for approved products.
The fine print
- CoreAge Rx's FAQ promises an automatic 100% refund if the clinician declines your prescription, but its refund policy says applicable consultation fees of $50–$100 are nonrefundable. Ask which policy applies to the exact order and how much would be returned before you pay.
- CoreAge Rx's refund policy makes a medication order final once the prescription is approved and sent to the pharmacy, which can happen before shipping. Waiting until the parcel is dispatched may be too late to cancel an order or recover the medication charge. The policy also imposes a 30-day nonrefundable cutoff even when incomplete documentation has prevented fulfillment.
- CoreAge Rx does not publish a complete GLP-1 state list. Its FAQ says therapy-specific state restrictions are confirmed during intake, so a U.S. address alone does not establish that your selected medication is available where you live.
- CoreAge Rx does not name the dispensing pharmacy in its FAQ; it asks patients to contact support. Obtain the pharmacy's legal name, license and contact information before choosing a compounded prescription. The platform's branding does not identify who prepares your medication.
- CoreAge Rx's FAQ says there are no automatic rebills, while its refund policy and help center describe optional automatic renewals. I would confirm the selected purchase option and next charge date rather than treat the general FAQ answer as a guarantee for every order.
- CoreAge Rx offers compounded medication, which is not FDA-approved. Its FAQ says tirzepatide is typically formulated with B12 and that requests without it go to the prescriber. Ask why the exact formulation is appropriate for you; an added vitamin does not itself establish a lawful patient-specific difference.
Luvo Health
Luvo prices compounded semaglutide at $209 and tirzepatide at $249 per four weeks, with tablets, microdosing and brand-name Ozempic® or Zepbound® on the same account.
What's good
- Luvo publishes its prices on each medication page, with no intake or quiz required to see a number
- Three real GLP-1 routes at Luvo — compounded injection, compounded oral tablet, and brand-name Ozempic®/Zepbound®
- Luvo's price covers the clinician review, medication and ongoing support, with no consult or membership fee
- A Luvo microdosing plan at $179 per four weeks for people who want to start on a low dose
- Full refund if a provider disqualifies you before medication is ordered
- Luvo is cash pay with no insurance needed, and you can cancel the subscription yourself from your Luvo account.
The fine print
- Luvo bills per 4 weeks, not per month, which is 13 charges a year rather than 12
- Luvo's first four weeks are half price, so the second charge ($209 semaglutide, $249 tirzepatide) is the one to budget from
- Luvo charges for the first period as soon as you complete the intake form, before a clinician has reviewed you
- Refunds at Luvo stop once medication is ordered, and cancellation needs 72 hours' notice before the next billing date
- Luvo does not publish the states it serves — confirm coverage before you sign up
- At Luvo, medication usually counts as ordered as soon as you submit the intake, unless a video visit is required, so the refund window can close the moment you sign up.
- Luvo's exact price is confirmed by a clinician after the intake, so the figure on the program card is a range until then.
We earn a commission when you start treatment through some links on this site, at no extra cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Luvo Health.
More head-to-heads
The programs scoring closest to this pair, side by side.
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. "% vs brand-name self-pay" compares a program's lowest disclosed monthly price against $349/mo, Wegovy's self-pay price at NovoCare Pharmacy, every standard dose after the two-month intro offer (checked October 2026). Prices change — confirm on each provider's site. Not medical advice; see our disclosure.